Medical Devices & Consumables
Global Recombinant Human LIF Protein Market Research Report 2025
- Jan 16, 26
- ID: 668492
- Pages: 88
- Figures: 87
- Views: 2
This report aims to provide a comprehensive presentation of the global market for Recombinant Human LIF Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human LIF Protein.
The Recombinant Human LIF Protein market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human LIF Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human LIF Protein companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STEMCELL
Merck
YEASEN
Dalian Meilun Biotech Co., Ltd.
R&D Systems, Inc.
Thermo Fisher Scientific Inc.
Cell Guidance Systems LLC
Prospec-Tany Technogene Ltd.
ACROBiosystems
Neuromics
BioLegend, Inc
InVitria
BPS Bioscience
ScienCell Research Laboratories, Inc
Segment by Type
Purity < 97%
Purity ≥ 97%
Segment by Application
Laboratory
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human LIF Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Recombinant Human LIF Protein market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human LIF Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human LIF Protein companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STEMCELL
Merck
YEASEN
Dalian Meilun Biotech Co., Ltd.
R&D Systems, Inc.
Thermo Fisher Scientific Inc.
Cell Guidance Systems LLC
Prospec-Tany Technogene Ltd.
ACROBiosystems
Neuromics
BioLegend, Inc
InVitria
BPS Bioscience
ScienCell Research Laboratories, Inc
Segment by Type
Purity < 97%
Purity ≥ 97%
Segment by Application
Laboratory
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human LIF Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human LIF Protein Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Market by Application
1.3.1 Global Recombinant Human LIF Protein Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human LIF Protein Market Perspective (2020-2031)
2.2 Global Recombinant Human LIF Protein Growth Trends by Region
2.2.1 Global Recombinant Human LIF Protein Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Human LIF Protein Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Human LIF Protein Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Human LIF Protein Market Dynamics
2.3.1 Recombinant Human LIF Protein Industry Trends
2.3.2 Recombinant Human LIF Protein Market Drivers
2.3.3 Recombinant Human LIF Protein Market Challenges
2.3.4 Recombinant Human LIF Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human LIF Protein Players by Revenue
3.1.1 Global Top Recombinant Human LIF Protein Players by Revenue (2020-2025)
3.1.2 Global Recombinant Human LIF Protein Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Human LIF Protein Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human LIF Protein Revenue
3.4 Global Recombinant Human LIF Protein Market Concentration Ratio
3.4.1 Global Recombinant Human LIF Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human LIF Protein Revenue in 2024
3.5 Global Key Players of Recombinant Human LIF Protein Head office and Area Served
3.6 Global Key Players of Recombinant Human LIF Protein, Product and Application
3.7 Global Key Players of Recombinant Human LIF Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human LIF Protein Breakdown Data by Type
4.1 Global Recombinant Human LIF Protein Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Human LIF Protein Forecasted Market Size by Type (2026-2031)
5 Recombinant Human LIF Protein Breakdown Data by Application
5.1 Global Recombinant Human LIF Protein Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Human LIF Protein Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Human LIF Protein Market Size (2020-2031)
6.2 North America Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Human LIF Protein Market Size by Country (2020-2025)
6.4 North America Recombinant Human LIF Protein Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human LIF Protein Market Size (2020-2031)
7.2 Europe Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Human LIF Protein Market Size by Country (2020-2025)
7.4 Europe Recombinant Human LIF Protein Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human LIF Protein Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Human LIF Protein Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human LIF Protein Market Size (2020-2031)
9.2 Latin America Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Human LIF Protein Market Size by Country (2020-2025)
9.4 Latin America Recombinant Human LIF Protein Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human LIF Protein Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STEMCELL
11.1.1 STEMCELL Company Details
11.1.2 STEMCELL Business Overview
11.1.3 STEMCELL Recombinant Human LIF Protein Introduction
11.1.4 STEMCELL Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.1.5 STEMCELL Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Recombinant Human LIF Protein Introduction
11.2.4 Merck Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.2.5 Merck Recent Development
11.3 YEASEN
11.3.1 YEASEN Company Details
11.3.2 YEASEN Business Overview
11.3.3 YEASEN Recombinant Human LIF Protein Introduction
11.3.4 YEASEN Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.3.5 YEASEN Recent Development
11.4 Dalian Meilun Biotech Co., Ltd.
11.4.1 Dalian Meilun Biotech Co., Ltd. Company Details
11.4.2 Dalian Meilun Biotech Co., Ltd. Business Overview
11.4.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human LIF Protein Introduction
11.4.4 Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.4.5 Dalian Meilun Biotech Co., Ltd. Recent Development
11.5 R&D Systems, Inc.
11.5.1 R&D Systems, Inc. Company Details
11.5.2 R&D Systems, Inc. Business Overview
11.5.3 R&D Systems, Inc. Recombinant Human LIF Protein Introduction
11.5.4 R&D Systems, Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.5.5 R&D Systems, Inc. Recent Development
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Details
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Recombinant Human LIF Protein Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.6.5 Thermo Fisher Scientific Inc. Recent Development
11.7 Cell Guidance Systems LLC
11.7.1 Cell Guidance Systems LLC Company Details
11.7.2 Cell Guidance Systems LLC Business Overview
11.7.3 Cell Guidance Systems LLC Recombinant Human LIF Protein Introduction
11.7.4 Cell Guidance Systems LLC Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.7.5 Cell Guidance Systems LLC Recent Development
11.8 Prospec-Tany Technogene Ltd.
11.8.1 Prospec-Tany Technogene Ltd. Company Details
11.8.2 Prospec-Tany Technogene Ltd. Business Overview
11.8.3 Prospec-Tany Technogene Ltd. Recombinant Human LIF Protein Introduction
11.8.4 Prospec-Tany Technogene Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.8.5 Prospec-Tany Technogene Ltd. Recent Development
11.9 ACROBiosystems
11.9.1 ACROBiosystems Company Details
11.9.2 ACROBiosystems Business Overview
11.9.3 ACROBiosystems Recombinant Human LIF Protein Introduction
11.9.4 ACROBiosystems Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.9.5 ACROBiosystems Recent Development
11.10 Neuromics
11.10.1 Neuromics Company Details
11.10.2 Neuromics Business Overview
11.10.3 Neuromics Recombinant Human LIF Protein Introduction
11.10.4 Neuromics Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.10.5 Neuromics Recent Development
11.11 BioLegend, Inc
11.11.1 BioLegend, Inc Company Details
11.11.2 BioLegend, Inc Business Overview
11.11.3 BioLegend, Inc Recombinant Human LIF Protein Introduction
11.11.4 BioLegend, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.11.5 BioLegend, Inc Recent Development
11.12 InVitria
11.12.1 InVitria Company Details
11.12.2 InVitria Business Overview
11.12.3 InVitria Recombinant Human LIF Protein Introduction
11.12.4 InVitria Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.12.5 InVitria Recent Development
11.13 BPS Bioscience
11.13.1 BPS Bioscience Company Details
11.13.2 BPS Bioscience Business Overview
11.13.3 BPS Bioscience Recombinant Human LIF Protein Introduction
11.13.4 BPS Bioscience Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.13.5 BPS Bioscience Recent Development
11.14 ScienCell Research Laboratories, Inc
11.14.1 ScienCell Research Laboratories, Inc Company Details
11.14.2 ScienCell Research Laboratories, Inc Business Overview
11.14.3 ScienCell Research Laboratories, Inc Recombinant Human LIF Protein Introduction
11.14.4 ScienCell Research Laboratories, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.14.5 ScienCell Research Laboratories, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human LIF Protein Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Purity < 97%
1.2.3 Purity ≥ 97%
1.3 Market by Application
1.3.1 Global Recombinant Human LIF Protein Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 University
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human LIF Protein Market Perspective (2020-2031)
2.2 Global Recombinant Human LIF Protein Growth Trends by Region
2.2.1 Global Recombinant Human LIF Protein Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Recombinant Human LIF Protein Historic Market Size by Region (2020-2025)
2.2.3 Recombinant Human LIF Protein Forecasted Market Size by Region (2026-2031)
2.3 Recombinant Human LIF Protein Market Dynamics
2.3.1 Recombinant Human LIF Protein Industry Trends
2.3.2 Recombinant Human LIF Protein Market Drivers
2.3.3 Recombinant Human LIF Protein Market Challenges
2.3.4 Recombinant Human LIF Protein Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human LIF Protein Players by Revenue
3.1.1 Global Top Recombinant Human LIF Protein Players by Revenue (2020-2025)
3.1.2 Global Recombinant Human LIF Protein Revenue Market Share by Players (2020-2025)
3.2 Global Top Recombinant Human LIF Protein Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human LIF Protein Revenue
3.4 Global Recombinant Human LIF Protein Market Concentration Ratio
3.4.1 Global Recombinant Human LIF Protein Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human LIF Protein Revenue in 2024
3.5 Global Key Players of Recombinant Human LIF Protein Head office and Area Served
3.6 Global Key Players of Recombinant Human LIF Protein, Product and Application
3.7 Global Key Players of Recombinant Human LIF Protein, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human LIF Protein Breakdown Data by Type
4.1 Global Recombinant Human LIF Protein Historic Market Size by Type (2020-2025)
4.2 Global Recombinant Human LIF Protein Forecasted Market Size by Type (2026-2031)
5 Recombinant Human LIF Protein Breakdown Data by Application
5.1 Global Recombinant Human LIF Protein Historic Market Size by Application (2020-2025)
5.2 Global Recombinant Human LIF Protein Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Recombinant Human LIF Protein Market Size (2020-2031)
6.2 North America Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Recombinant Human LIF Protein Market Size by Country (2020-2025)
6.4 North America Recombinant Human LIF Protein Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human LIF Protein Market Size (2020-2031)
7.2 Europe Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Recombinant Human LIF Protein Market Size by Country (2020-2025)
7.4 Europe Recombinant Human LIF Protein Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human LIF Protein Market Size (2020-2031)
8.2 Asia-Pacific Recombinant Human LIF Protein Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2020-2025)
8.4 Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human LIF Protein Market Size (2020-2031)
9.2 Latin America Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Recombinant Human LIF Protein Market Size by Country (2020-2025)
9.4 Latin America Recombinant Human LIF Protein Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human LIF Protein Market Size (2020-2031)
10.2 Middle East & Africa Recombinant Human LIF Protein Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2020-2025)
10.4 Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STEMCELL
11.1.1 STEMCELL Company Details
11.1.2 STEMCELL Business Overview
11.1.3 STEMCELL Recombinant Human LIF Protein Introduction
11.1.4 STEMCELL Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.1.5 STEMCELL Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Recombinant Human LIF Protein Introduction
11.2.4 Merck Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.2.5 Merck Recent Development
11.3 YEASEN
11.3.1 YEASEN Company Details
11.3.2 YEASEN Business Overview
11.3.3 YEASEN Recombinant Human LIF Protein Introduction
11.3.4 YEASEN Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.3.5 YEASEN Recent Development
11.4 Dalian Meilun Biotech Co., Ltd.
11.4.1 Dalian Meilun Biotech Co., Ltd. Company Details
11.4.2 Dalian Meilun Biotech Co., Ltd. Business Overview
11.4.3 Dalian Meilun Biotech Co., Ltd. Recombinant Human LIF Protein Introduction
11.4.4 Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.4.5 Dalian Meilun Biotech Co., Ltd. Recent Development
11.5 R&D Systems, Inc.
11.5.1 R&D Systems, Inc. Company Details
11.5.2 R&D Systems, Inc. Business Overview
11.5.3 R&D Systems, Inc. Recombinant Human LIF Protein Introduction
11.5.4 R&D Systems, Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.5.5 R&D Systems, Inc. Recent Development
11.6 Thermo Fisher Scientific Inc.
11.6.1 Thermo Fisher Scientific Inc. Company Details
11.6.2 Thermo Fisher Scientific Inc. Business Overview
11.6.3 Thermo Fisher Scientific Inc. Recombinant Human LIF Protein Introduction
11.6.4 Thermo Fisher Scientific Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.6.5 Thermo Fisher Scientific Inc. Recent Development
11.7 Cell Guidance Systems LLC
11.7.1 Cell Guidance Systems LLC Company Details
11.7.2 Cell Guidance Systems LLC Business Overview
11.7.3 Cell Guidance Systems LLC Recombinant Human LIF Protein Introduction
11.7.4 Cell Guidance Systems LLC Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.7.5 Cell Guidance Systems LLC Recent Development
11.8 Prospec-Tany Technogene Ltd.
11.8.1 Prospec-Tany Technogene Ltd. Company Details
11.8.2 Prospec-Tany Technogene Ltd. Business Overview
11.8.3 Prospec-Tany Technogene Ltd. Recombinant Human LIF Protein Introduction
11.8.4 Prospec-Tany Technogene Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.8.5 Prospec-Tany Technogene Ltd. Recent Development
11.9 ACROBiosystems
11.9.1 ACROBiosystems Company Details
11.9.2 ACROBiosystems Business Overview
11.9.3 ACROBiosystems Recombinant Human LIF Protein Introduction
11.9.4 ACROBiosystems Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.9.5 ACROBiosystems Recent Development
11.10 Neuromics
11.10.1 Neuromics Company Details
11.10.2 Neuromics Business Overview
11.10.3 Neuromics Recombinant Human LIF Protein Introduction
11.10.4 Neuromics Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.10.5 Neuromics Recent Development
11.11 BioLegend, Inc
11.11.1 BioLegend, Inc Company Details
11.11.2 BioLegend, Inc Business Overview
11.11.3 BioLegend, Inc Recombinant Human LIF Protein Introduction
11.11.4 BioLegend, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.11.5 BioLegend, Inc Recent Development
11.12 InVitria
11.12.1 InVitria Company Details
11.12.2 InVitria Business Overview
11.12.3 InVitria Recombinant Human LIF Protein Introduction
11.12.4 InVitria Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.12.5 InVitria Recent Development
11.13 BPS Bioscience
11.13.1 BPS Bioscience Company Details
11.13.2 BPS Bioscience Business Overview
11.13.3 BPS Bioscience Recombinant Human LIF Protein Introduction
11.13.4 BPS Bioscience Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.13.5 BPS Bioscience Recent Development
11.14 ScienCell Research Laboratories, Inc
11.14.1 ScienCell Research Laboratories, Inc Company Details
11.14.2 ScienCell Research Laboratories, Inc Business Overview
11.14.3 ScienCell Research Laboratories, Inc Recombinant Human LIF Protein Introduction
11.14.4 ScienCell Research Laboratories, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025)
11.14.5 ScienCell Research Laboratories, Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Recombinant Human LIF Protein Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Purity < 97%
Table 3. Key Players of Purity ≥ 97%
Table 4. Global Recombinant Human LIF Protein Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant Human LIF Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant Human LIF Protein Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant Human LIF Protein Market Share by Region (2020-2025)
Table 8. Global Recombinant Human LIF Protein Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant Human LIF Protein Market Share by Region (2026-2031)
Table 10. Recombinant Human LIF Protein Market Trends
Table 11. Recombinant Human LIF Protein Market Drivers
Table 12. Recombinant Human LIF Protein Market Challenges
Table 13. Recombinant Human LIF Protein Market Restraints
Table 14. Global Recombinant Human LIF Protein Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant Human LIF Protein Market Share by Players (2020-2025)
Table 16. Global Top Recombinant Human LIF Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human LIF Protein as of 2024)
Table 17. Ranking of Global Top Recombinant Human LIF Protein Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant Human LIF Protein Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant Human LIF Protein, Headquarters and Area Served
Table 20. Global Key Players of Recombinant Human LIF Protein, Product and Application
Table 21. Global Key Players of Recombinant Human LIF Protein, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Human LIF Protein Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant Human LIF Protein Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant Human LIF Protein Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant Human LIF Protein Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant Human LIF Protein Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant Human LIF Protein Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant Human LIF Protein Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant Human LIF Protein Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant Human LIF Protein Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 46. STEMCELL Company Details
Table 47. STEMCELL Business Overview
Table 48. STEMCELL Recombinant Human LIF Protein Product
Table 49. STEMCELL Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 50. STEMCELL Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Recombinant Human LIF Protein Product
Table 54. Merck Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. YEASEN Company Details
Table 57. YEASEN Business Overview
Table 58. YEASEN Recombinant Human LIF Protein Product
Table 59. YEASEN Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 60. YEASEN Recent Development
Table 61. Dalian Meilun Biotech Co., Ltd. Company Details
Table 62. Dalian Meilun Biotech Co., Ltd. Business Overview
Table 63. Dalian Meilun Biotech Co., Ltd. Recombinant Human LIF Protein Product
Table 64. Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 65. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 66. R&D Systems, Inc. Company Details
Table 67. R&D Systems, Inc. Business Overview
Table 68. R&D Systems, Inc. Recombinant Human LIF Protein Product
Table 69. R&D Systems, Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 70. R&D Systems, Inc. Recent Development
Table 71. Thermo Fisher Scientific Inc. Company Details
Table 72. Thermo Fisher Scientific Inc. Business Overview
Table 73. Thermo Fisher Scientific Inc. Recombinant Human LIF Protein Product
Table 74. Thermo Fisher Scientific Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Inc. Recent Development
Table 76. Cell Guidance Systems LLC Company Details
Table 77. Cell Guidance Systems LLC Business Overview
Table 78. Cell Guidance Systems LLC Recombinant Human LIF Protein Product
Table 79. Cell Guidance Systems LLC Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 80. Cell Guidance Systems LLC Recent Development
Table 81. Prospec-Tany Technogene Ltd. Company Details
Table 82. Prospec-Tany Technogene Ltd. Business Overview
Table 83. Prospec-Tany Technogene Ltd. Recombinant Human LIF Protein Product
Table 84. Prospec-Tany Technogene Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 85. Prospec-Tany Technogene Ltd. Recent Development
Table 86. ACROBiosystems Company Details
Table 87. ACROBiosystems Business Overview
Table 88. ACROBiosystems Recombinant Human LIF Protein Product
Table 89. ACROBiosystems Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 90. ACROBiosystems Recent Development
Table 91. Neuromics Company Details
Table 92. Neuromics Business Overview
Table 93. Neuromics Recombinant Human LIF Protein Product
Table 94. Neuromics Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 95. Neuromics Recent Development
Table 96. BioLegend, Inc Company Details
Table 97. BioLegend, Inc Business Overview
Table 98. BioLegend, Inc Recombinant Human LIF Protein Product
Table 99. BioLegend, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 100. BioLegend, Inc Recent Development
Table 101. InVitria Company Details
Table 102. InVitria Business Overview
Table 103. InVitria Recombinant Human LIF Protein Product
Table 104. InVitria Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 105. InVitria Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Human LIF Protein Product
Table 109. BPS Bioscience Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. ScienCell Research Laboratories, Inc Company Details
Table 112. ScienCell Research Laboratories, Inc Business Overview
Table 113. ScienCell Research Laboratories, Inc Recombinant Human LIF Protein Product
Table 114. ScienCell Research Laboratories, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 115. ScienCell Research Laboratories, Inc Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Recombinant Human LIF Protein Picture
Figure 2. Global Recombinant Human LIF Protein Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human LIF Protein Market Share by Type: 2024 VS 2031
Figure 4. Purity < 97% Features
Figure 5. Purity ≥ 97% Features
Figure 6. Global Recombinant Human LIF Protein Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human LIF Protein Market Share by Application: 2024 VS 2031
Figure 8. Laboratory Case Studies
Figure 9. University Case Studies
Figure 10. Others Case Studies
Figure 11. Recombinant Human LIF Protein Report Years Considered
Figure 12. Global Recombinant Human LIF Protein Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Recombinant Human LIF Protein Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Recombinant Human LIF Protein Market Share by Region: 2024 VS 2031
Figure 15. Global Recombinant Human LIF Protein Market Share by Players in 2024
Figure 16. Global Recombinant Human LIF Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human LIF Protein Revenue in 2024
Figure 18. North America Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 20. United States Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 24. Germany Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Recombinant Human LIF Protein Market Share by Region (2020-2031)
Figure 32. China Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 40. Mexico Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 44. Turkey Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. STEMCELL Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 49. YEASEN Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 50. Dalian Meilun Biotech Co., Ltd. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 51. R&D Systems, Inc. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 53. Cell Guidance Systems LLC Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 54. Prospec-Tany Technogene Ltd. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 55. ACROBiosystems Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 56. Neuromics Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 57. BioLegend, Inc Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 58. InVitria Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 59. BPS Bioscience Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 60. ScienCell Research Laboratories, Inc Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Recombinant Human LIF Protein Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Purity < 97%
Table 3. Key Players of Purity ≥ 97%
Table 4. Global Recombinant Human LIF Protein Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Recombinant Human LIF Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Recombinant Human LIF Protein Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Recombinant Human LIF Protein Market Share by Region (2020-2025)
Table 8. Global Recombinant Human LIF Protein Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Recombinant Human LIF Protein Market Share by Region (2026-2031)
Table 10. Recombinant Human LIF Protein Market Trends
Table 11. Recombinant Human LIF Protein Market Drivers
Table 12. Recombinant Human LIF Protein Market Challenges
Table 13. Recombinant Human LIF Protein Market Restraints
Table 14. Global Recombinant Human LIF Protein Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Recombinant Human LIF Protein Market Share by Players (2020-2025)
Table 16. Global Top Recombinant Human LIF Protein Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human LIF Protein as of 2024)
Table 17. Ranking of Global Top Recombinant Human LIF Protein Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Recombinant Human LIF Protein Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Recombinant Human LIF Protein, Headquarters and Area Served
Table 20. Global Key Players of Recombinant Human LIF Protein, Product and Application
Table 21. Global Key Players of Recombinant Human LIF Protein, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant Human LIF Protein Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Recombinant Human LIF Protein Revenue Market Share by Type (2020-2025)
Table 25. Global Recombinant Human LIF Protein Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Recombinant Human LIF Protein Revenue Market Share by Type (2026-2031)
Table 27. Global Recombinant Human LIF Protein Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Recombinant Human LIF Protein Revenue Market Share by Application (2020-2025)
Table 29. Global Recombinant Human LIF Protein Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Recombinant Human LIF Protein Revenue Market Share by Application (2026-2031)
Table 31. North America Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Recombinant Human LIF Protein Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Recombinant Human LIF Protein Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Recombinant Human LIF Protein Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Recombinant Human LIF Protein Market Size by Country (2026-2031) & (US$ Million)
Table 46. STEMCELL Company Details
Table 47. STEMCELL Business Overview
Table 48. STEMCELL Recombinant Human LIF Protein Product
Table 49. STEMCELL Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 50. STEMCELL Recent Development
Table 51. Merck Company Details
Table 52. Merck Business Overview
Table 53. Merck Recombinant Human LIF Protein Product
Table 54. Merck Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 55. Merck Recent Development
Table 56. YEASEN Company Details
Table 57. YEASEN Business Overview
Table 58. YEASEN Recombinant Human LIF Protein Product
Table 59. YEASEN Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 60. YEASEN Recent Development
Table 61. Dalian Meilun Biotech Co., Ltd. Company Details
Table 62. Dalian Meilun Biotech Co., Ltd. Business Overview
Table 63. Dalian Meilun Biotech Co., Ltd. Recombinant Human LIF Protein Product
Table 64. Dalian Meilun Biotech Co., Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 65. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 66. R&D Systems, Inc. Company Details
Table 67. R&D Systems, Inc. Business Overview
Table 68. R&D Systems, Inc. Recombinant Human LIF Protein Product
Table 69. R&D Systems, Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 70. R&D Systems, Inc. Recent Development
Table 71. Thermo Fisher Scientific Inc. Company Details
Table 72. Thermo Fisher Scientific Inc. Business Overview
Table 73. Thermo Fisher Scientific Inc. Recombinant Human LIF Protein Product
Table 74. Thermo Fisher Scientific Inc. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 75. Thermo Fisher Scientific Inc. Recent Development
Table 76. Cell Guidance Systems LLC Company Details
Table 77. Cell Guidance Systems LLC Business Overview
Table 78. Cell Guidance Systems LLC Recombinant Human LIF Protein Product
Table 79. Cell Guidance Systems LLC Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 80. Cell Guidance Systems LLC Recent Development
Table 81. Prospec-Tany Technogene Ltd. Company Details
Table 82. Prospec-Tany Technogene Ltd. Business Overview
Table 83. Prospec-Tany Technogene Ltd. Recombinant Human LIF Protein Product
Table 84. Prospec-Tany Technogene Ltd. Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 85. Prospec-Tany Technogene Ltd. Recent Development
Table 86. ACROBiosystems Company Details
Table 87. ACROBiosystems Business Overview
Table 88. ACROBiosystems Recombinant Human LIF Protein Product
Table 89. ACROBiosystems Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 90. ACROBiosystems Recent Development
Table 91. Neuromics Company Details
Table 92. Neuromics Business Overview
Table 93. Neuromics Recombinant Human LIF Protein Product
Table 94. Neuromics Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 95. Neuromics Recent Development
Table 96. BioLegend, Inc Company Details
Table 97. BioLegend, Inc Business Overview
Table 98. BioLegend, Inc Recombinant Human LIF Protein Product
Table 99. BioLegend, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 100. BioLegend, Inc Recent Development
Table 101. InVitria Company Details
Table 102. InVitria Business Overview
Table 103. InVitria Recombinant Human LIF Protein Product
Table 104. InVitria Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 105. InVitria Recent Development
Table 106. BPS Bioscience Company Details
Table 107. BPS Bioscience Business Overview
Table 108. BPS Bioscience Recombinant Human LIF Protein Product
Table 109. BPS Bioscience Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 110. BPS Bioscience Recent Development
Table 111. ScienCell Research Laboratories, Inc Company Details
Table 112. ScienCell Research Laboratories, Inc Business Overview
Table 113. ScienCell Research Laboratories, Inc Recombinant Human LIF Protein Product
Table 114. ScienCell Research Laboratories, Inc Revenue in Recombinant Human LIF Protein Business (2020-2025) & (US$ Million)
Table 115. ScienCell Research Laboratories, Inc Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Recombinant Human LIF Protein Picture
Figure 2. Global Recombinant Human LIF Protein Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Recombinant Human LIF Protein Market Share by Type: 2024 VS 2031
Figure 4. Purity < 97% Features
Figure 5. Purity ≥ 97% Features
Figure 6. Global Recombinant Human LIF Protein Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Recombinant Human LIF Protein Market Share by Application: 2024 VS 2031
Figure 8. Laboratory Case Studies
Figure 9. University Case Studies
Figure 10. Others Case Studies
Figure 11. Recombinant Human LIF Protein Report Years Considered
Figure 12. Global Recombinant Human LIF Protein Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Recombinant Human LIF Protein Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Recombinant Human LIF Protein Market Share by Region: 2024 VS 2031
Figure 15. Global Recombinant Human LIF Protein Market Share by Players in 2024
Figure 16. Global Recombinant Human LIF Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Recombinant Human LIF Protein Revenue in 2024
Figure 18. North America Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 20. United States Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 24. Germany Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Recombinant Human LIF Protein Market Share by Region (2020-2031)
Figure 32. China Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 40. Mexico Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Recombinant Human LIF Protein Market Share by Country (2020-2031)
Figure 44. Turkey Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Recombinant Human LIF Protein Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. STEMCELL Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 48. Merck Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 49. YEASEN Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 50. Dalian Meilun Biotech Co., Ltd. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 51. R&D Systems, Inc. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 53. Cell Guidance Systems LLC Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 54. Prospec-Tany Technogene Ltd. Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 55. ACROBiosystems Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 56. Neuromics Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 57. BioLegend, Inc Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 58. InVitria Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 59. BPS Bioscience Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 60. ScienCell Research Laboratories, Inc Revenue Growth Rate in Recombinant Human LIF Protein Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232